Kainova Therapeutics
PrivateLast Round
Series B
Feb 10, 2026
Total Funding Raised
$76.21M
Momentum Score
50 /100
Company Overview
Kainova Therapeutics is a clinical-stage biopharmaceutical company that develops a pipeline of G protein-coupled receptor (GPCR)-modulating therapies for immuno-oncology and inflammation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kainova Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Kainova Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 10, 2026 | ||||
| Series A | May 10, 2022 | ||||
| Debt | Jan 13, 2020 | ||||
| Early Funding | May 28, 2019 | ||||
| VC Round | Jul 17, 2012 |
Kainova Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Series B |
| IP Group | VC Round |
| CTI Life Sciences Fund | Series B, Series A |
| 3B FUTURE Health Fund | Series B, Series A |
| Turenne Groupe | Series B, Series A |
| Viva BioInnovator | Series B, Series A |
| Caisse d'Epargne Grand-Est Europe | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Grew 16% QoQ, from 38 to 44 employees.
Kainova Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kainova Therapeutics's valuation, stock price, and market status.
